Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
AbbVie
David W Dodick; Peter J Goadsby; Todd J Schwedt; Richard B Lipton; Chengcheng Liu; Kaifeng Lu; Sung Yun Yu; Lawrence Severt; Michelle Finnegan; Joel M Trugman